Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.25p
   
  • Change Today:
    -0.50p
  • 52 Week High: 82.00p
  • 52 Week Low: 2.00p
  • Currency: UK Pounds
  • Shares Issued: 95.77m
  • Volume: 1,196,097
  • Market Cap: £2.15m
  • RiskGrade: 410

Destiny Pharma Overview

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem of anti-microbial resistance (AMR).

1 Day Chart (26-07-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 0.3  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Destiny Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a (5.52) (10.66)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (6.48) (12.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (6.27) (8.90)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (7.71) (9.30)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (6.45) (6.20)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Destiny Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 n/a (6.29) (6.50)p n/a n/a n/a n/a 0.0%
31-Dec-25 n/a (8.00) (8.50)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Destiny Pharma Company Announcements

Proposed Cancellation of Admission to Trading 15-Jul-2024 07:00 RNS
Exercise of Options and Total Voting Rights 20-Jun-2024 07:00 RNS
Efficacy of XF-70 in Fungal Skin Infections 18-Jun-2024 07:00 RNS

Destiny Pharma ShareCast News

Destiny Pharma reports progress on clinical assets 04-Jan-2024 ShareCast
Sunday share tips: Destiny Pharma, Invinity Ener... 29-Oct-2023 ShareCast
Destiny Pharma loss widens as it extends cash ru... 13-Apr-2023 ShareCast

Destiny Pharma Top Newspaper Links

Nigel Rudd: Destiny Pharma must quit AIM to avoi... 15-Jul-2024 Times

Latest Destiny Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 2.25p
Change Today -0.50p
% Change -18.18 %
52 Week High 82.00p
52 Week Low 2.00p
Volume 1,196,097
Shares Issued 95.77m
Market Cap £2.15m
RiskGrade 410

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
64.30% above the market average64.30% above the market average64.30% above the market average64.30% above the market average64.30% above the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average
Price Trend
98.59% below the market average98.59% below the market average98.59% below the market average98.59% below the market average98.59% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Destiny Pharma Dividends

No dividends found

Trades for 26-Jul-2024

Time Volume / Share Price
16:29 50,000 @ 2.44p
16:29 50,000 @ 2.44p
16:27 20,491 @ 2.44p
16:23 21,367 @ 2.34p
16:19 60,000 @ 2.34p

Destiny Pharma Key Personnel

CEO Chris Tovey

Top of Page